Sign in
A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
Website

A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use

David Price, Yumi Asukai, Jaithri Ananthapavan, Bill Malcolm, Amr Radwan and Ian Keyzor
06/2013

Abstract

HB Economic Theory R Medicine
Peer reviewed Publisher PDF

Metrics

1 Record Views

Details